Molecule Details
| InChIKey | JFACETXYABVHFD-WXPPGMDDSA-N |
|---|---|
| Compound Name | Pristimerin |
| Canonical SMILES | COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=CC(=O)C(O)=C5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.63 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB17049 |
|---|---|
| Drug Name | Pristimerin |
| CAS Number | 1258-84-0 |
| Groups | experimental |
| ATC Codes | nan |
| Description | Pristimerin is a quinone methide triterpenoid researched for its anti-cancer potential.[A253107] |
Categories: Terpenes Triterpenes
Cross-references: BindingDB: 50481947 ChEBI: 8416 CHEMBL54804 ChemSpider: 140269 C08633 ZINC: ZINC000004097723